ENDOU Gene Research Notes

Gene Overview

ENDOU (Endonuclease, Poly(U) specific) encodes a uridylate-specific endoribonuclease, also known as human placental protein 11 (PP11). Originally misidentified as a serine protease, it was later demonstrated to be an RNA endonuclease with poly(U) specificity.

Primary Function and Biochemical Properties

Endoribonuclease Activity

• Primary function: Uridylate-specific endoribonuclease that cleaves single-stranded RNA at uridine-rich sequences PMID:18936097
• Substrate specificity: Preferentially cleaves at UU or GU dinucleotides PMID:18936097
• Metal cofactor requirement: Mn²⁺-dependent activity, unlike classical RNase A PMID:18936097
• Cleavage products: Generates 2′,3′-cyclic phosphate termini on cleaved RNA fragments PMID:18936097

Catalytic Mechanism

• Active site: Contains a conserved His–His–Lys catalytic triad similar to RNase A
• Enzymatic classification: EC 3.1.-.- (endoribonuclease) and EC 4.6.1.- (lyase activity)
• NOT a protease: Despite original annotation, ENDOU has no detectable serine protease activity PMID:18936097

Structural Features

Domain Architecture

• Signal peptide: N-terminal hydrophobic signal sequence (18 amino acids) for secretion PMID:2350438
• Somatomedin B domain: Contains a single somatomedin B domain at the N-terminus PMID:1710108
• EndoU domain: C-terminal endoribonuclease domain with conserved His–His–Lys catalytic triad
• Total length: 410 amino acids (approximately 46.9 kDa mature protein)

Evolutionary Conservation

• Homologs: Related to Xenopus XendoU and viral coronavirus Nsp15 endoribonucleases
• Conservation: EndoU family proteins are evolutionarily conserved across eukaryotes and some viruses
• Functional rescue: Human ENDOU can rescue Drosophila Arlr mutants, demonstrating functional conservation PMID:37803019

Expression Patterns and Cellular Localization

Tissue-Specific Expression

• Placenta: Highly expressed in placental syncytiotrophoblasts PMID:2350438
• Tumor tissues: Aberrantly expressed in various cancers, particularly ovarian carcinomas
• 66.7% of mucinous ovarian cystadenocarcinomas express PP11 PMID:6755403
• 57.1% of serous ovarian cystadenocarcinomas express PP11 PMID:6755403
• Normal tissues: Generally low expression in most adult tissues except placenta

Subcellular Localization

• Secreted protein: Directed to secretory pathway by N-terminal signal peptide
• Extracellular region: Functions primarily in extracellular space [GO:0005576]
• Cytoplasmic: Also detected in cytoplasm of secretory cells prior to secretion [GO:0005737]
• ER localization: Colocalizes with ER markers during processing

Biological Functions and Processes

RNA Metabolism

• RNA catabolic process: Involved in degradation of specific RNA substrates [GO:0016075]
• RNA processing: May participate in processing of small nucleolar RNAs (snoRNAs) by analogy to Xenopus XendoU
• Post-transcriptional regulation: Implicated in post-transcriptional gene silencing [GO:0016441]

Lipid Homeostasis (Novel Function)

• Lipid metabolism regulation: Acts as a negative regulator of lipolysis PMID:37803019
• mRNA degradation mechanism: Degrades mRNAs of lipolytic genes to maintain lipid storage
• Age-related function: Drosophila ortholog (Arlr) is essential for lipid accumulation during aging PMID:37803019
• Functional conservation: Human ENDOU can rescue lipid defects in Drosophila Arlr mutants PMID:37803019

Immune System Function

• B cell tolerance: Mouse studies suggest role in activation-induced cell death (AICD) of B cells
• Peripheral tolerance: May contribute to elimination of auto-reactive B lymphocytes

Disease Associations

Cancer Biology

• Tumor marker: Originally identified as a diagnostic tumor marker PMID:2350438
• Oncofetal expression: Expression pattern similar to oncofetal antigens (high in tumors and placenta, low in normal adult tissues)
• Ovarian cancer: Particularly elevated in ovarian adenocarcinomas PMID:6755403
• Diagnostic potential: Proposed as molecular marker for tumor diagnosis

Pregnancy and Development

• Placental function: Highly expressed during pregnancy in placental tissue [GO:0007565 female pregnancy]
• Trophoblast biology: May play role in trophoblast invasion and placental development

Functional Interactions and Pathways

Molecular Function Annotations

• RNA binding: Direct RNA binding capability [GO:0003723] PMID:18936097
• RNA endonuclease activity: Primary molecular function [GO:0004521]
• Metal ion binding: Requires manganese ions for activity [GO:0030145]
• Growth factor activity: Suggested growth factor-like properties [GO:0008083]

Regulatory Networks

• Lipolysis pathway: Negatively regulates lipolytic gene expression
• RNA surveillance: May participate in RNA quality control mechanisms
• Stress response: Potentially involved in cellular stress responses during aging

Research Significance and Open Questions

Key Discoveries

1. Functional reclassification: Major paradigm shift from serine protease to endoribonuclease PMID:18936097
2. Lipid homeostasis role: Novel function in metabolic regulation discovered through Drosophila studies PMID:37803019
3. Evolutionary conservation: Functional rescue across species demonstrates conserved role

Outstanding Questions

• What are the specific endogenous RNA substrates in human cells?
• How is ENDOU expression regulated during development and in disease?
• What is the precise role in human lipid metabolism?
• How does ENDOU contribute to immune tolerance in humans?
• What are the structural determinants of RNA substrate specificity?

Therapeutic Potential

• Cancer therapy: Potential target for cancer treatment given tumor-specific expression
• Metabolic disorders: Possible therapeutic target for lipid metabolism disorders
• Diagnostic applications: Continued utility as tumor biomarker

Summary

ENDOU represents a fascinating example of gene function evolution and misannotation correction. Originally thought to be a serine protease, it is actually a unique uridylate-specific endoribonuclease with roles in RNA metabolism, lipid homeostasis, and potentially immune regulation. Its expression in placenta and tumors, combined with its newly discovered metabolic functions, makes it an important gene for understanding both normal physiology and disease pathogenesis.

Review verification pass (2026-06-15)

Ran a critical verification pass (annotation-reviewer skill) over the already-COMPLETE review. Verified all key claims against cached full texts. Changes applied:

1. Metal cofactor reconciliation. PMID:40169637 (1.7 Å crystal structure of human EndoU) shows the eukaryotic enzyme is specifically Ca2+-activated: "only calcium stimulated cleavage, unlike manganese or other divalent metals." This updates the earlier in vitro Mn2+ report (PMID:18936097, bacterially expressed His-PP11). Updated description and the metal-related core_functions to present this tension rather than asserting Mn2+-dependence as settled fact. Kept GO:0030145 manganese ion binding (TAS) as ACCEPT — defensible as historically reported.
2. GO:0006417 → GO:0045727 (positive regulation of translation). PMID:33511665 is explicitly directional — ENDOU "enhance[s] CHOP mRNA translation"; overexpression "increased CHOP expression" in human HEK293T/HeLa (and zebrafish). Positive term preferred.
3. GO:0006915 → GO:0043065 (positive regulation of apoptotic process). PMID:24344237 is a mouse study; "EndoU gene disruption prevents AICD and normalizes c-Myc" → EndoU is pro-apoptotic. Flagged organism = mouse (ortholog transfer) in both this and the GO:0002514 reasons.
4. GO:0016829 lyase — kept ACCEPT but corrected the muddled "elimination" reasoning: UniProt assigns EC 4.6.1.- (phosphorus-oxygen lyase) alongside EC 3.1.-.- and carries KW-0456; the 2',3'-cyclic-phosphate-forming transesterification is a deliberate current lyase classification.
5. Quote quality. Replaced several title-only supporting_text quotes (negated peptidase, CHOP ER-stress/translation, B-cell, calcium) with substantive findings from the full texts.
6. Added reference_review (relevance/correctness/notes) for the four verified primary full-text references (PMID:18936097, 33511665, 24344237, 37803019, 40169637).

The other decisions (REMOVEs for signal transduction, scavenger receptor, polysaccharide binding, growth factor activity, plasma membrane, proteolysis, serine peptidase IDA; negated-peptidase ACCEPT; lipid/RNA-endonuclease ACCEPTs; B-cell tolerance MODIFY) were all re-verified and left unchanged. File re-validates.

Falcon deep research re-run (2026-06-15)

Attempted a fresh falcon deep research run (deep_research_wrapper.py human ENDOU falcon --fallback perplexity-lite). It could not complete in this environment: the falcon provider requires the agentapi binary, which is not in PATH (WARNING - agentapi not found in PATH), so it hung until its 600s timeout; the perplexity-lite fallback is not a registered provider here (Available: falcon, asta, openscientist), so the run ended with "All providers failed" and no new -deep-research-falcon.md was written.

Instead I re-mined the existing falcon deep research (ENDOU-deep-research-falcon.md, generated 2026-05-29). Its core findings were already incorporated (endoribonuclease activity, 2',3'-cyclic phosphate products, Mn2+/Ca2+, catalytic residues, syncytiotrophoblast/cytoplasm localization, PE-FGR upregulation, Drosophila Arlr rescue, RNase-A evolutionary link). The one genuinely new dimension was an oncology angle, which I verified against PubMed and incorporated:

• PMID:33614471 (Xu et al., Front Oncol 2021, DOI 10.3389/fonc.2020.522332): ENDOU is downregulated in HNSCC and acts as a tumor suppressor — overexpression inhibits proliferation and migration of FaDu/Cal-27 cells; independent survival marker; lower in HPV+ tumors. PMID:33614471
• PMID:34712364 (Bašić et al., Oncol Lett 2021, DOI 10.3892/ol.2021.13101): ENDOU downregulated in cervical SCC (1% IHC positivity in tumors vs 40% in non-tumor). PMID:34712364

Both PMIDs were fetched/cached (full text from PMC) and added to references: with reference_review. I deliberately did not mint new core GO annotations (e.g. GO:0008285 negative regulation of cell population proliferation) from these single cancer-cell-line/expression studies — that would be over-annotation and inconsistent with ENDOU's physiological core function. The oncofetal-marker-vs-tumor-suppressor tension is captured as a new suggested_questions entry.